General Information of the Compound
Compound ID
CP0072527
Compound Name
SCH772984
    Show/Hide
Synonyms
SCH-772984
SCH772984
    Show/Hide
Structure
Formula
C33H33N9O2
Molecular Weight
587.688
Canonical SMILES
O=C(CN1CC[C@@H](C1)C(=O)Nc1ccc2[nH]nc(-c3ccncc3)c2c1)N1CCN(CC1)c1ccc(cc1)-c1ncccn1
    Show/Hide
InChI
InChI=1S/C33H33N9O2/c43-30(42-18-16-41(17-19-42)27-5-2-24(3-6-27)32-35-11-1-12-36-32)22-40-15-10-25(21-40)33(44)37-26-4-7-29-28(20-26)31(39-38-29)23-8-13-34-14-9-23/h1-9,11-14,20,25H,10,15-19,21-22H2,(H,37,44)(H,38,39)/t25-/m1/s1
    Show/Hide
InChIKey
HDAJDNHIBCDLQF-RUZDIDTESA-N
Physicochemical Property
logP
3.6911
Rotatable Bonds
7
Heavy Atom Count
44
Polar Areas
123.24
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
8
Complexity
44

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 24866313
SID: 50099060
ChEMBL ID
CHEMBL3590107
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00850, Mitogen-activated protein kinase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000045 A-375 Homo sapiens (Human)  2
1
IC50 = 4 nM
   TI
   LI
   LO
   TS
2
IC50 = 20 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 < 0.3 nM
2 IC50 = 0.4 nM
3 IC50 = 1 nM
4 Kd = 0.05012 nM
5 Kd = 0.1 nM
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000045 A-375 Homo sapiens (Human)  1
1
IC50 = 70 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( SCH772984 )
Drug Name SCH772984
Target(s)
Extracellular signal-regulated kinase 2 (ERK2)
Inhibitor